ELTE Department of English Applied Linguistics | Budapest
PDF) Impact of multiple switching on health care costs and outcomes in generic drug policies: The Hungarian case of losartan
EPHA on Twitter: ""#Valletta has not reached any real progress yet. We are exchanging knowledge, taking steps towards #transparency, but real progress is not yet there." Paola Testori Coggi @Aifa_ufficiale #Trailblazers2025" /
ISPOR - Zoltán Kaló, PhD
ELTE Reader
Modeling Cost-Effectiveness of Cervical Cancer Screening in Hungary
Colleagues – Center for Health Technology Assessment
About us - Hungary - Selfie 2020 -
Health Care Challenges in Central & Eastern European Countries - YouTube
Transferability of HTA between countries - ppt download
PDF) Policy objective of generic medicines from the investment perspective: The case of clopidogrel
„A kulcs a tudatos tervezés”
Zoltán Kaló - Professor of Health Economics - Center for Health Technology Assessment, Semmelweis University | LinkedIn
Prof. Zoltán Kaló PhD András Borsi PhD(c)
kalo@tatk.elte.hu 1
Steps of economic evaluation Decision rule & sensitivity analysis - ppt download
MANAGING THE INTRODUCTION OF NEW AND HIGH-COST DRUGS IN CHALLENGING TIMES: THE EXPERIENCE OF HUNGARY AND POLAND
A HAZAI GYÓGYSZERPOLITIKA KOCKÁZATAI: KÉRDEZZE MEG KEZELŐORVOSÁT, GYÓGYSZERÉSZÉT! Kaló Zoltán Egészség-gazdaságt
II. ELTE Biotechnológia FIEK szimpózium
Prof. Dr. Zoltan Kalo | Medicines for Europe
ELTE Reader
ELTE Reader
Sağlık Bilimleri Üniversitesi - Sağlık Ekonomisi Eğitimi Programı 2
ELTE Reader
Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries
Balázs Nagy – Jonathan D. Campbell – Zoltán Kaló (eds): The role of modelling in economic evaluations in health care | ELTE Reader
Health Policy, Planning and Financing MSc ELTE by ELTE TáTK - Issuu
